There are bad actors out there, purporting to be compounding pharmacies that are licensed in specific states or have the credentials to be able to compound when in actuality they dont, said Carter
healthcare providers wrote more than 9 million prescriptions for Wegovy, Ozempic, and other GLP-1 agonists in the last three months of 2022 alone
Zepbound just received its FDA approval in 2023
This discussion should cover: Your current progress: How well are you doing on your current medication regarding weight loss, blood sugar control, and overall well-being
Recent research suggests that oral semaglutide may be as effective, if not more so, than its injectable counterpart in some individuals
federal regulators to make a decision on whether to approve orforglipron for obesity as soon as this spring